SUMMARY Thirty-one patients with rheumatoid arthritis maintained on prednisolone 5 mg daily for an average period of 9 4 years were assessed radiologically to determine the degree of osteoporosis in their spine and peripheral skeleton. They were compared with a control group of 32 rheumatoid patients who had never received corticosteroids. The steroid-treated patients had more severe osteoporosis than the controls, though the difference was not statistically significant. In the female patients the spine appeared to be more sensitive than the peripheral skeleton to the osteoporotic effect of corticosteroids.
Osteoporosis is a recognised complication of rheumatoid arthritis (RA), with juxta-articular involvement occurring in the early stages of the disease. A more generalised form may follow affecting the axial as well as the appendicular skeleton.1`3 The pathophysiology of osteoporosis is still unknown, though many aetiological factors have been implicated. 4 In patients with RA such factors may include immobilisation, poor nutrition, chronic inflammation, and corticosteroid therapy.5 The part played by low-dose corticosteroids is not entirely clear, and various studies have produced conflicting results.' 6-12 A major difficulty has been the lack of accurate and sensitive tests to assess the degree of osteoporosis. Newer techniques, such as the estimation of total body calcium as measured by neutron activation analysis, can provide an objective assessment of osteoporosis. This method, however, cannot give a differential assessment of the various parts of the skeleton. Although radiological methods may have their drawbacks,'" they do allow a differential study of the skeletion to be made.
The object of the present study was to investigate the effect of oral prednisolone 5 mg daily on the axial and appendicular skeleton of patients with RA.
Patients and methods
Thirty-two consecutive outpatients with RA receiving prednisolone 5 Barnett and Nordin" (the sum of the thickness of the 'medial' and 'lateral' cortices of the shaft divided by the diameter and multiplied by 100). The points of measurement were the mid point of the metacarpal and 14 cm from the lesser trochanter along the femur. Only the homogeneous and compact bone was measured. Vertebral body density was graded by the method of Saville3 as follows: Grade 1: minimal loss of bone Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis 25 
Results
Details of the patients are shown in Table 1 . The duration of corticosteroid therapy ranged from 3 to 23 years with a mean of 9 4 years. The biochemical indices of all the patients were normal except for a minimally elevated AP in 5 patients, in 4 of whom the -yGT was also raised. Both enzyme abnormalities were considered to be of liver origin as may sometimes be seen in patients with RA.16 Table 2 shows the average metacarpal and femoral scores. Patients in the steroid group generally had lower scores, indicating a thinner cortex. However, the difference between the 2 groups was not statistically significant (p > 0 5). When the postmenopausal female patients of the 2 groups were compared, the difference was slightly greater but still failed to reach statistical significance (0-1<p<05).
The grades of spinal density for all the patients in the 2 groups are shown in Table 3 . Severe osteoporosis (grades 3 and 4) was commoner among patients of the steroid group as compared with the control group. This difference, however, was not statistically significant (01<p<0 5). When the female patients of the 2 groups were compared, the difference was greater, but once again it failed to reach statistical significance (0-05<p<0-1). Similar results were found among the postmenopausal female patients. For male patients the effect of steroid therapy on spinal porosity was even less apparent.
Discussion
The part played by low-dose corticosteroid therapy in Other methods used for the assessment of osteoporosis included photon absorptiometry" and neutron activation analysis, which estimates total body calcium.11 12 Although these methods are considered to be more sensitive, they cannot demonstrate differential loss of bone density. Riggs et al. " reported that the central and peripheral skeletons may develop different degrees of osteoporosis, and Howland et al."9 described more severe osteoporosis in the axial than in the appendicular skeleton of patients with Cushing's disease. In view of these observations it would seem important to examine both the peripheral and central skeleton independently for the assessment of osteoporosis in patients with RA who have been on long-term lowdose corticosteroid therapy.
We assessed osteoporosis of the peripheral skeleton by measuring the metacarpal and femoral cortex, while osteoporosis of the central skeleton was assessed by examining the third lumbar and adjacent vertebrae. Our results suggest that there is a tendency to more severe osteoporosis in the corticosteroidtreated patients both in the spine and in the periphery. The difference, however, from the control group was not statistically significant. We also noted that in female patients the central skeleton appeared to be more sensitive than the peripheral skeleton to the effect of corticosteroids. This finding would support Howland's observation on the distribution of osteoporosis in patients with Cushing's disease.1"
Thus it would seem that long-term corticosteroid therapy with doses no greater than 5 
